Compare MKZR & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MKZR | AIDX |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 2.9M |
| IPO Year | 2012 | 2025 |
| Metric | MKZR | AIDX |
|---|---|---|
| Price | $1.03 | $0.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.4K | ★ 206.0K |
| Earning Date | 12-01-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.87 | 34.48 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $20,007,414.00 | $2,045,133.00 |
| Revenue This Year | N/A | $44.20 |
| Revenue Next Year | N/A | $95.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 16.71 |
| 52 Week Low | $0.83 | $0.18 |
| 52 Week High | $5.22 | $18.96 |
| Indicator | MKZR | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 49.55 | 30.30 |
| Support Level | $1.01 | N/A |
| Resistance Level | $1.23 | $0.27 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 60.89 | 0.00 |
Mackenzie Realty Capital Inc is a real estate investment manager and a real estate investment trust (REIT) engaged in discounted real estate securities and asset management. The Company operates through two primary operating and reportable segments: commercial, which generates maximum revenue, and residential. These segments include activities related to acquiring, owning, developing, and managing income-producing real estate properties. Its properties are geographically diversified throughout the United States.
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.